InvestorsHub Logo
Followers 8
Posts 1036
Boards Moderated 0
Alias Born 10/26/2015

Re: xblkbk post# 287744

Thursday, 07/23/2020 11:00:19 PM

Thursday, July 23, 2020 11:00:19 PM

Post# of 425636
I saw that interview. At least he didn't mention anti inflammatory characteristics that Vascepa has. The 1970's Fenofibrate got 15 seconds of attention but I'll patiently wait for Vascepa P3 study that we'll learn results on in the coming months.
Like JL mentioned earlier today, we may be nearing a unforeseen bonanza of Vascepa therapeutics that may be worthy of a larger market than ever anticipated by the end of our 2030 R-It patents.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News